'Right To Try' Bills Raise New Hurdles For Drug Approvals

Bills letting terminally ill patients access unapproved medications are suddenly attracting strong support among lawmakers in multiple states, pressuring drugmakers to sell experimental products even though approval prospects can dim if...

Already a subscriber? Click here to view full article